Compare Atectura to Other Asthma Inhalers

October 2020

Atectura Breezhaler will be a new combo inhaler jostling for a place in the asthma market.

It contains indacaterol (Onbrez) and mometasone (Asmanex).

Atectura is the fifth combo of an inhaled corticosteroid and long-acting beta-agonist approved for asthma maintenance...after Advair, Breo, Symbicort, and Zenhale.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Immunizations Answer Questions About Vaccinations During COVID-19
Supplements Know Which Supplements Promoted for COVID-19 May Be Risky
Contraceptives Be Ready to Answer Questions About Nexplanon Contraceptive Implant
Med Safety Put Skin Cancer Risk With Hydrochlorothiazide in Perspective
Substance Use Disorder Address Barriers to Treating Opioid Use Disorder During COVID-19
Asthma Compare Atectura to Other Asthma Inhalers
Menopause Consider Tibella for Patients Who Don't Tolerate Hormone Therapy
Immunology Be Prepared to Treat Patients With Hereditary Angioedema
Osteoporosis Explain How Meds for Postmenopausal Osteoporosis Stack Up
Stroke Don't Jump to Ticagrelor Plus Aspirin After Stroke

Compare Atectura to Other Asthma Inhalers

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents